Mental Health Research Accelerator Act of 2025 provides tax credit for translational research on neurodegenerative diseases and psychiatric.

The Mental Health Research Accelerator Act of 2025 amends the Internal Revenue Code to offer a tax credit for expenses related to translational research on neurodegenerative diseases and psychiatric conditions. The credit is equal to 25% of the expenses incurred by the taxpayer. The bill sets a national limitation on the credit, with specific amounts allocated for each year from 2026 to 2031. The credit is designed to incentivize research through public-private partnerships, with priority given to collaborative efforts and intellectual property sharing.

Mental Health Research Accelerator Act of 2025 provides tax credit for translational research on neurodegenerative diseases and psychiatric.

The Mental Health Research Accelerator Act of 2025 amends the Internal Revenue Code to offer a tax credit for expenses related to translational research on neurodegenerative diseases and psychiatric conditions. The credit is equal to 25% of the expenses incurred by the taxpayer. The bill sets a national limitation on the credit, with specific amounts allocated for each year from 2026 to 2031. The credit is designed to incentivize research through public-private partnerships, with priority given to collaborative efforts and intellectual property sharing.